Cargando…
Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687265/ https://www.ncbi.nlm.nih.gov/pubmed/23801811 http://dx.doi.org/10.2337/dc13-0376 |
| _version_ | 1782273891552460800 |
|---|---|
| author | Satoh-Asahara, Noriko Shimatsu, Akira Wada, Hiromichi Suganami, Takayoshi Hasegawa, Koji Ogawa, Yoshihiro |
| author_facet | Satoh-Asahara, Noriko Shimatsu, Akira Wada, Hiromichi Suganami, Takayoshi Hasegawa, Koji Ogawa, Yoshihiro |
| author_sort | Satoh-Asahara, Noriko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3687265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36872652014-07-01 Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 Satoh-Asahara, Noriko Shimatsu, Akira Wada, Hiromichi Suganami, Takayoshi Hasegawa, Koji Ogawa, Yoshihiro Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687265/ /pubmed/23801811 http://dx.doi.org/10.2337/dc13-0376 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Satoh-Asahara, Noriko Shimatsu, Akira Wada, Hiromichi Suganami, Takayoshi Hasegawa, Koji Ogawa, Yoshihiro Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title | Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title_full | Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title_fullStr | Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title_full_unstemmed | Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title_short | Response to Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 |
| title_sort | response to comment on: satoh-asahara et al. highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. diabetes care 2012;35:2631–2639 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687265/ https://www.ncbi.nlm.nih.gov/pubmed/23801811 http://dx.doi.org/10.2337/dc13-0376 |
| work_keys_str_mv | AT satohasaharanoriko responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 AT shimatsuakira responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 AT wadahiromichi responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 AT suganamitakayoshi responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 AT hasegawakoji responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 AT ogawayoshihiro responsetocommentonsatohasaharaetalhighlypurifiedeicosapentaenoicacidincreasesinterleukin10levelsofperipheralbloodmonocytesinobesepatientswithdyslipidemiadiabetescare20123526312639 |